-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Tenet Healthcare, Lowers Price Target to $238

Benzinga·05/05/2026 14:53:15
Listen to the news
Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and lowers the price target from $257 to $238.